Speedy Summary
- A study examined the effectiveness of the migraine medication rizatriptan in treating vestibular migraines,which cause vertigo,headache,and light sensitivity.
- 134 adults participated in a randomized trial where they took either 10 mg of rizatriptan or a placebo during 307 moderate-to-severe episodes.
- After one hour-when rizatriptan reaches peak concentration-it was found to be no more effective than a placebo for relieving symptoms like vertigo or balance issues.
- A slight betterment was noted after 24 hours in sensitivity to motion, light, and sound and also physical well-being, but not mental well-being or vertigo relief.
- Findings indicate that vestibular systems involved in these migraines may differ from pathways targeted by triptans (the drug class to which rizatriptan belongs).
- Experts suggest a need for targeted treatments specific to vestibular migraine symptoms and greater dialogue between clinicians diagnosing patients.
!campaign=RSS%7CNSNS&utmsource=NSNS&utmmedium=RSS&utm_content=home”>here.